About Bio Voyager

Pioneering the Future

of Longevity Science

Who We Are

Bio Voyager is a biotechnology research company founded in 2024 and headquartered in Tampa, Florida. We specialize in gene expression modulation, with a primary focus on telomere biology and cellular rejuvenation. Our mission is to discover and develop breakthrough molecules and gene therapies that can extend healthy human lifespan by addressing one of the fundamental mechanisms of aging.

We work at the cutting edge of molecular biology to activate key longevity genes, particularly hTERT (telomerase), which extends telomeres and helps cells maintain their youthful state. In addition, we research other important targets including:
  • Follistatin & Myostatin pathways (muscle growth)
  • MC1R (hair graying reversal)
  • IL-17A and GSK3 (inflammation)
  • Fetuin B (regenerative pathways)
  • Leaky Gut (Gut Bacteria Gain of Function)
  • Cell Preservation (keeping cells for next centuries)
Why We Can Deliver Results

Using advanced High-Throughput Screening (HTS) and GFP reporter assays, we rapidly identify powerful new compounds.

We also develop AAV-based gene therapies for long-term gene expression.

Dragan Nikolic, MS

MS at Medical Microbiology and Biochemistry at Univeristy of FLorida.
30 Years business experience.

CEO

Dr. Dejan Slavnic, DO

20 Years as Neuro Surgeon . and 10 Years of business experience.

CFO

Dan Black, PhD

PhD in molecular Biology, Former professor at Colorado Boulder. 40 Years Leading Laboratory Researcher.

COO

Sasa Milic, MS

30 Years as Professor. Leading European figure in statistics and software engineering.

CTO

Why We Can Deliver Results

World-Class Facilities

We operate our own laboratory in Tampa and maintain active research partnerships with University of South Florida (USF) and University of Florida (UF).

Advanced Technology

Proprietary high-throughput systems capable of screening up to 100,000 compounds.

Expert Team

Led by scientists and clinicians with deep specialization in microbiology, biochemistry, and neurosurgery.

Focused Approach

All our research is strictly preclinical and designed for rapid translation into pharmaceutical and nutraceutical applications.

We offer a clear division of strengths

We Are Looking for Partners & Investors

Bio Voyager is actively seeking strategic partners and investors who share our vision of advancing longevity science.

We do the science

discovery, validation, and technology development

You bring

manufacturing, regulatory expertise, marketing, and global distribution

Partnership Models Include

  • Licensing of discovered compounds
  • Joint development of nutraceutical or pharmaceutical products
  • Technology transfer of AAV gene therapies
  • Custom research projects
  • We are open to both investment and collaboration opportunities. Serious partners are invited to contact us directly for confidential discussions and detailed data packages.
Contact Us

Disclaimer

All research conducted by Bio Voyager is preclinical. Our compounds, assays, and gene therapies are intended for further research and commercial development only and are not approved for human use.